208 related articles for article (PubMed ID: 29776011)
1. Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer.
Corter AL; Broom R; Porter D; Harvey V; Findlay M
Psychooncology; 2018 Sep; 27(9):2096-2103. PubMed ID: 29776011
[TBL] [Abstract][Full Text] [Related]
2. Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer.
Corter AL; Findlay M; Broom R; Porter D; Petrie KJ
Br J Health Psychol; 2013 Feb; 18(1):168-81. PubMed ID: 23134580
[TBL] [Abstract][Full Text] [Related]
3. Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer.
Bender CM; Gentry AL; Brufsky AM; Casillo FE; Cohen SM; Dailey MM; Donovan HS; Dunbar-Jacob J; Jankowitz RC; Rosenzweig MQ; Sherwood PR; Sereika SM
Oncol Nurs Forum; 2014 May; 41(3):274-85. PubMed ID: 24769592
[TBL] [Abstract][Full Text] [Related]
4. Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.
Simon R; Latreille J; Matte C; Desjardins P; Bergeron E
Can J Surg; 2014 Feb; 57(1):26-32. PubMed ID: 24461223
[TBL] [Abstract][Full Text] [Related]
5. Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey.
Tinari N; Fanizza C; Romero M; Gambale E; Moscetti L; Vaccaro A; Seminara P; Longo F; Gori S; Vici P; Gamucci T; Mauri M; Laudadio L; Nuzzo A; Fabbri MA; Fattoruso SI; Mazzilli L; Grassadonia A; Cianchetti E; Natoli C
Clin Breast Cancer; 2015 Apr; 15(2):e131-7. PubMed ID: 25454738
[TBL] [Abstract][Full Text] [Related]
6. Endocrine therapy for breast cancer: assessing an array of women's treatment experiences and perceptions, their perceived self-efficacy and nonadherence.
Wouters H; Stiggelbout AM; Bouvy ML; Maatman GA; Van Geffen EC; Vree R; Nortier JW; Van Dijk L
Clin Breast Cancer; 2014 Dec; 14(6):460-467.e2. PubMed ID: 24981234
[TBL] [Abstract][Full Text] [Related]
7. Clinical profiles predict early nonadherence to adjuvant endocrine treatment in a prospective breast cancer cohort.
Markkula A; Hietala M; Henningson M; Ingvar C; Rose C; Jernström H
Cancer Prev Res (Phila); 2012 May; 5(5):735-45. PubMed ID: 22401981
[TBL] [Abstract][Full Text] [Related]
8. Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
Brier MJ; Chambless DL; Gross R; Chen J; Mao JJ
Cancer; 2017 Jan; 123(1):169-176. PubMed ID: 27570979
[TBL] [Abstract][Full Text] [Related]
9. Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross-sectional survey.
Xu H; Jin F; Zhang XJ; Wang DQ; Yu SF; Wang AP
Cancer Med; 2020 Jun; 9(11):3703-3713. PubMed ID: 32237070
[TBL] [Abstract][Full Text] [Related]
10. Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer.
Salgado TM; Davis EJ; Farris KB; Fawaz S; Batra P; Henry NL
Breast Cancer Res Treat; 2017 Jun; 163(2):311-319. PubMed ID: 28251384
[TBL] [Abstract][Full Text] [Related]
11. Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer.
Walker HE; Rosenberg SM; Stanton AL; Petrie KJ; Partridge AH
J Adolesc Young Adult Oncol; 2016 Mar; 5(1):16-23. PubMed ID: 26812461
[TBL] [Abstract][Full Text] [Related]
12. Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
Kuba S; Maeda S; Matsumoto M; Yamanouchi K; Yano H; Morita M; Sakimura C; Hatachi T; Tokai Y; Takatsuki M; Fujioka H; Hayashida N; Nagayasu T; Eguchi S
Clin Breast Cancer; 2018 Apr; 18(2):150-156. PubMed ID: 29290564
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment predictors of short-term nonadherence to oral hormonal therapy for women with breast cancer.
Wickersham KE; Sereika SM; Bender CM
Nurs Res; 2013; 62(4):243-51. PubMed ID: 23817282
[TBL] [Abstract][Full Text] [Related]
14. Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.
Kimmick G; Edmond SN; Bosworth HB; Peppercorn J; Marcom PK; Blackwell K; Keefe FJ; Shelby RA
Breast; 2015 Oct; 24(5):630-6. PubMed ID: 26189978
[TBL] [Abstract][Full Text] [Related]
15. Nonadherence to tamoxifen in breast cancer survivors: A 12 month longitudinal analysis.
Moon Z; Moss-Morris R; Hunter MS; Norton S; Hughes LD
Health Psychol; 2019 Oct; 38(10):888-899. PubMed ID: 31343218
[TBL] [Abstract][Full Text] [Related]
16. Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer.
Bright EE; Petrie KJ; Partridge AH; Stanton AL
Breast Cancer Res Treat; 2016 Jul; 158(2):243-51. PubMed ID: 27342455
[TBL] [Abstract][Full Text] [Related]
17. Women's experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour.
Cahir C; Dombrowski SU; Kelly CM; Kennedy MJ; Bennett K; Sharp L
Support Care Cancer; 2015 Nov; 23(11):3115-30. PubMed ID: 25744290
[TBL] [Abstract][Full Text] [Related]
18. Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry.
Stanton AL; Petrie KJ; Partridge AH
Breast Cancer Res Treat; 2014 Jun; 145(2):525-34. PubMed ID: 24781972
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: A qualitative evidence synthesis.
Clancy C; Lynch J; OConnor P; Dowling M
Eur J Oncol Nurs; 2020 Feb; 44():101706. PubMed ID: 32007696
[TBL] [Abstract][Full Text] [Related]
20. Disentangling breast cancer patients' perceptions and experiences with regard to endocrine therapy: nature and relevance for non-adherence.
Wouters H; van Geffen EC; Baas-Thijssen MC; Krol-Warmerdam EM; Stiggelbout AM; Belitser S; Bouvy ML; van Dijk L
Breast; 2013 Oct; 22(5):661-6. PubMed ID: 23770134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
